| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V4793 | PHT-7.3 | 1614225-93-2 | PHT-7.3 is a novel, potent and selective inhibitor ofconnector enhancer of kinase suppressor of Ras 1 (Cnk1)which is a pleckstrin homology (PH) domain-containing scaffold protein that increases the efficiency of Ras signaling pathways, imparting efficiency and specificity to the response of cell proliferation, survival, and migration. |
|
V5153 | PI-828 | 942289-87-4 | PI-828 is a dual PI3K and casein kinase 2 (CK2) inhibitor that can suppress p110α, CK2 and CK2α2 with IC50 of 173 nM, 149 nM and 1127 nM respectively. |
|
V4964 | Pi-Methylimidazoleacetic acid | 4200-48-0 | Pi-Methylimidazoleacetic acid is a potential neurotoxin. |
|
V4966 | PI3K-IN-6 | 1842380-77-1 | PI3K-IN-6 (compound 20a in related reference: J Med Chem. |
|
V4981 | PI3K/HDAC-IN-1 | PI3K/HDAC-IN-1 is a novel, potent and dual inhibitor ofPI3K and HDAC, itpotently inhibits PI3Kδ and HDAC1 withIC50s of 8.1 nM and 1.4 nM, respectively. | |
|
V4990 | PI3K/mTOR Inhibitor-1 | 1949802-49-6 | PI3K/mTOR Inhibitor-1, aSulfonyl-Substituted Morpholinopyrimidines based analog, is a novel, potent, orally bioavailable dualPI3K/mTORinhibitor with potential antitumor activity. |
|
V4986 | PI3Kdelta inhibitor 1 | 2242109-74-4 | PI3Kdelta inhibitor 1 (Compound 5d in referenceBioorg Med Chem. |
|
V4989 | PI3Kα/mTOR-IN-1 | 1013098-90-2 | PI3Kα/mTOR-IN-1, a 4-methylpyrido pyrimidinone (MPP) analog, is a novel and potent PI3Kα/mTOR dual inhibitor, with anIC50of 7 nM for PI3Kα in a cell assay, andKis of 10.6 nM and 12.5 nM for mTOR and PI3Kα in a cell free assay , respectively. |
|
V4980 | PI3Kγ inhibitor 2 | 1315538-79-4 | PI3Kγ inhibitor 2 (Compound 16 in referenceJ Med Chem. |
|
V4992 | PI3kδ inhibitor 1 | 1332075-63-4 | PI3kδ inhibitor 1 is a novel, potent and selectivePI3Kδinhibitor with anIC50of 3.8 nM. |
|
V4969 | PI3Kδ-IN-1 | 1911564-39-0 | PI3Kδ-IN-1 is a novel, potent, selective, and efficacious PI3Kδ inhibitor with an IC50of 1.7 nM. |
|
V4987 | PI4KIII beta inhibitor 3 | 1245319-54-3 | PI4KIII beta inhibitor 3, extracted fromWO 2013034738 A1, is a novel and potent PI4KIIIβ inhibitor with IC50of 5.7 nM. |
|
V5071 | Pomiferin (NSC 5113) | 572-03-2 | Pomiferin (formerly known as NSC 5113) is a naturally occuring flavonoid isolated from the fruits ofMaclura pomifera, which acts as an potential inhibitor ofHDAC, with anIC50of 1.05 μM, and also potently inhibitsmTOR(IC50, 6.2 µM). |
|
V4756 | PQR-530 | 1927857-61-1 | PQR-530 is a novel, potent, orally bioavailable and brain-penetrant dual pan-PI3K/mTORC1/2inhibitor, it exhibits antitumor activity. |
|
V4984 | PR-104 | 851627-62-8 | PR-104, a novel, potent, non-toxic, small-molecule, hypoxia-activated, 3,5-dinitrobenzamide nitrogen mustard, is a drug from the class of hypoxia-activated prodrugs (HAPs), which is being researched as a potential anti-cancer therapeutic agent. |
|
V4535 | PROTAC ABL binding moiety 2 | 778277-37-5 | PROTAC ABL binding moiety 2 is the GNF5 (an ABL inhibitor) moiety that binds to IAP (inhibitor of apoptosis protein) ligand via a linker to form SNIPER. |
|
V4742 | PROTAC BET Degrader-3 | PROTAC BET Degrader-3 is a PROTAC protein degrader linked by von Hippel-Lindau ligand and BET ligand. | |
|
V4744 | PROTAC-PEG3-Amino | 189808-70-6 | NH2-PEG3-C1-Boc (PROTAC (PROteolysis TArgeting Chimera) linker 5) is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category. |
|
V4745 | PROTAC-PEG3-Benene sulfonyl | 1246999-33-6 | Tos-PEG4-NH-Boc (PROTAC (PROteolysis TArgeting Chimera) linker 7) is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category. |
|
V4954 | PRX933 HCl | 639029-42-8 | PRX933 HCl, the hydrochloride salt form of PRX933 which is extracted from patent WO 2014140631 A1, is a novel and potent 5-HT2creceptor agonist |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
